- Three (3) consecutive days with an ANC ≥ 500 cells/mm3. [Notes: For sites where standard site practice is to monitor white blood count (WBC) early after transplant as opposed to ANC, then engraftment will be defined as WBC increasing for 3 consecutive days with an ANC ≥ 500 cell/mm3 on the third day. For non-myeloablative or reduced-intensity transplants (i.e., mini-transplants) where ANC does not fall below 500 cells/mm3, the site definition of engraftment should be used.] Able to ingest and absorb oral medication (in the judgment of the investigator and based on lack of significant GI events). [Note: Use of TPN (total parenteral nutrition) is not in and of itself exclusionary as long as the reason for use would not disqualify the patient based on this criterion.]